Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918

Clinical trial NCT00733031 · TERMINATED

Trial details

NCT number: NCT00733031
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer,Solid Tumors Advanced Solid Malignancies

Start date: 2008-08-01
Primary completion: 2009-03-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.